Stopping Patient Attrition Before it Starts: A Proactive Approach to Healthcare Marketing
When patients disengage, preventive care is missed, chronic conditions worsen, care shifts to higher-cost settings such as the emergency department and urgent care, and patients fragment across systems, reducing continuity.
Is Shah Capital’s Criticism of Novavax Fair? A Wall Street Analyst Weighs In
Himanshu Shah, an activist investor and large shareholder of Novavax, whose stock has plummeted over the years, believes the company should cut costs more aggressively, reduce the size of its board, and do more to prop up its financial performance. But are the criticisms valid?
Obsidian, Galera Merger Comes With $350M Infusion for Cancer Drug Trials
Obsidian Therapeutics aims to show its TIL cell therapy has advantages over an Iovance Biotherapeutics TIL therapy marketed for treating melanoma. Obsidian’s merger with Galera Therapeutics will give it a public listing and a private placement to support clinical development of the combined company’s cancer drug pipeline.
Expanding the CJR Model Is a Logical Step in VBC, but Implementation Challenges Remain
CMS is proposing to make its joint replacement bundled payment model mandatory nationwide. Experts say it is a logical step, but warn that mandatory participation could be challenging for hospitals to implement.
How Team-Based and Virtual Nursing Models Are Redefining Care Delivery
Care delivery doesn’t have to be binary — in-person or virtual, old model or new. It can be adaptive, team-based, and deeply human.